Diabetes UK Partners with Government to Address CVD – EMJ
Diabetes UK has partnered with the Department of Health & Social Care to educate the public on links between cardiovascular disease and diabetes,
Diabetes UK has partnered with the Department of Health & Social Care to educate the public on links between cardiovascular disease and diabetes,
ONE in four adults with Type 2 diabetes experience clinically significant hearing loss, a new systematic review and meta-analysis has found.1 This was particularly apparent in younger adults
Cardiac arrest rhythm recognition improved significantly among newly hired emergency medical service (EMS) providers, with team-based learning and individual learning producing equivalent short-term gains
MEN living with HIV are significantly more likely to experience premature ejaculation (PE) and depressive symptoms than HIV-negative individuals, according to findings from
MYELODYSPLASTIC syndromes may be more accurately stratified using a molecular evolution framework that integrates genomic trajectories with clinical data, improving prediction
BALANCED fluid did not reduce major adverse kidney events compared with saline in children treated for septic shock. A large
THE ALZHEIMER’S Association announced at AAIC 2026 the launch of PROTECT-Cog, a new global trial testing whether combining lifestyle interventions
Merck has announced FDA approval for enlicitide, the first FDA-approved once-daily oral pill designed to lower low-density lipoprotein cholesterol (LDL-C)
The European Medical Journal (EMJ) has been shortlisted for the Marketing Week Awards 2026. EMJ has been named a finalist
Image: Juno Bio Juno Bio, a women’s health company focused on precision vaginal microbiome testing and multi-omics, has opened a